What is PROCEPT BioRobotics?
PROCEPT BioRobotics is a surgical robotics for urology company serving providers, patients, payers, hospitals, labs, and life-sciences operators.
- Category
- Surgical robotics for urology
- Headquarters
- San Jose, CA
- Founded
- See official company history
- Employees
- See latest annual report and company filings
- Total funding
- Public company
- Status
- Public company; Nasdaq: PRCT
What is PROCEPT BioRobotics?
PROCEPT BioRobotics is a surgical robotics for urology company headquartered in San Jose, CA.
PROCEPT BioRobotics operates in surgical robotics for urology and is included here as a public company account for sales research and directory coverage. Its official website and investor-facing materials position the business around AquaBeam Robotic System, Aquablation therapy, BPH treatment, with a buying center that usually spans finance, operations, IT, procurement, legal, and line-of-business leadership.
For sellers, PROCEPT BioRobotics is useful to profile because public-company signals make account planning more concrete. Current annual reports, investor presentations, earnings releases, job posts, product launches, facility expansion, and partner announcements are stronger signals than stale third-party summaries.
What does PROCEPT BioRobotics offer?
PROCEPT BioRobotics's profile centers on AquaBeam Robotic System, Aquablation therapy, BPH treatment, Surgical robotics.
- AquaBeam Robotic System· Surgical robotics for urology
- Aquablation therapy· Surgical robotics for urology
- BPH treatment· Surgical robotics for urology
- Surgical robotics· Surgical robotics for urology
- Procedure planning· Surgical robotics for urology
- Hospital training· Surgical robotics for urology
How does PROCEPT BioRobotics make money?
PROCEPT BioRobotics makes money through commercial activity tied to surgical robotics for urology.
PROCEPT BioRobotics makes money through commercial activity tied to surgical robotics for urology. Depending on the operating unit, revenue may come from product sales, subscriptions, transaction fees, services, usage, occupancy, routing density, channel programs, or long-term customer contracts.
The practical growth levers are market expansion, pricing, utilization, operating efficiency, customer retention, product attach, supply-chain execution, and capital allocation. Relevant outreach should connect to measurable initiatives such as margin improvement, uptime, automation, compliance, customer experience, field productivity, or data quality.
Who leads PROCEPT BioRobotics?
PROCEPT BioRobotics's named executives should be verified on the official leadership or investor-relations page before outreach.
- PROCEPT BioRobotics executive leadershipExecutive leadership teamCurrent as of June 2026Use the official leadership, governance, or investor-relations page for current named executives before outreach.
- PROCEPT BioRobotics finance leadershipFinance / CFO organizationCurrent as of June 2026Often owns investor communication, procurement governance, and budget discipline.
- PROCEPT BioRobotics operations or technology leadershipOperations, product, technology, security, or commercial leadershipCurrent as of June 2026Likely stakeholder group for software, infrastructure, data, workflow, and operational-improvement purchases.
How do you contact PROCEPT BioRobotics's leadership?
PROCEPT BioRobotics should be contacted through official investor, media, partner, support, or sales routes unless a named executive publishes a direct address.
contact via https://www.procept-biorobotics.com- PROCEPT BioRobotics investor relationsInvestor relations / corporate contactcontact via https://www.procept-biorobotics.com
- PROCEPT BioRobotics sales or partnershipsCommercial contact routecontact via https://www.procept-biorobotics.com
- PROCEPT BioRobotics media relationsMedia or communications contact routecontact via https://www.procept-biorobotics.com
How is PROCEPT BioRobotics funded?
PROCEPT BioRobotics's current status is Public company; Nasdaq: PRCT.
PROCEPT BioRobotics's current capital profile is best understood through its listed public-company status: Public company; Nasdaq: PRCT. For public companies, financing and budget signals are usually found in annual reports, quarterly results, debt disclosures, buybacks, acquisitions, capital expenditure plans, and management commentary rather than venture funding rounds.
Before outreach, verify the latest status on the company's investor relations page and current exchange filings. Budget timing should be inferred from current initiatives, leadership priorities, geographic expansion, product launches, facility investments, and earnings-call commentary.
How did PROCEPT BioRobotics get here?
PROCEPT BioRobotics's history should be read through founding, scale-up, public-market ownership, and current product or market focus.
- FoundingPROCEPT BioRobotics is foundedThe company begins building in surgical robotics for urology.
- Scale-upCommercial footprint expandsPROCEPT BioRobotics broadens its product, customer, or geographic reach.
- Public marketsPublic company; Nasdaq: PRCTPublic-company ownership shapes reporting, procurement, and operating priorities.
- 2025Scaled operating profileThe company operates with specialized teams and repeatable buying centers.
- June 2026Current profile refreshedProfile generated from official domain, public-company status, and source references.
Who are PROCEPT BioRobotics's competitors?
PROCEPT BioRobotics competes with larger incumbents and focused specialists in surgical robotics for urology.
- MedtronicGlobal medical technology incumbent.
- Boston ScientificLarge interventional medical-device competitor.
- AbbottHealthcare company spanning diagnostics, devices, nutrition, and diabetes care.
- StrykerOrthopedics, neurotechnology, and surgical-equipment company.
- Cardinal HealthHealthcare distribution and services provider.
PROCEPT BioRobotics — frequently asked questions
